Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-571-3 | CAS number: 97-30-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- skin irritation: guideline study, OECD 439, GLP, in vitro: not irritating
- eye irritation: guideline study, OECD 437, GLP, in vitro: not irritating
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-03-06 to 2017-05-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- July 28, 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- July 06, 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- This test method provides an in vitro procedure that, depending on information requirements, may allow determining the cytotoxic potency and skin irritancy of test items as a stand-alone replacement test within a testing strategy, in a weight of evidence approach. The procedure described under this test method allows the hazard identification of irritant substances in accordance with UN GHS Category 1 or Category 2.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: Epiderm™
- Tissue batch number(s): EPI-200, Lot no. 25803
- Date of initiation of testing: 2017-03-14
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37°C for 35 min and room temperature for the last 25 min
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: not reported
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3h
- Spectrophotometer: Tecan Sunrise Magellan Version 7.2
- Wavelength: 540 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: The preferred assay for determining the magnitude of viability is the MTT assay. The optical density (OD) of the extraction solvent alone should be sufficiently small, i.e. OD < 0.1. The tissue treated with the negative control (NC) should exhibit stability in culture (provide similar viability measurements) for the duration of the test exposure period.
- Barrier function: The EpiDerm™ System was manufactured according to defined quality assurance procedures. All biological components of the epidermis and the culture medium were tested by manufacturer for viral, bacterial, fungal and mycoplasma contamination. MatTek Corporation determines the ET 50 value following exposure to Triton X-100 (1%) for each EpiDerm lot. The ET 50 must fall within a range established based on a historical database of results. ET-50 assay: 100µL 1% Triton x-100, 4 time points, n = 3, MTT assay: Acceptance criteria: ET-50 [4.77-8.72], Result: 5.36h.
- Contamination: HIV-1, Hepatitis B virus, Hepatitis C virus, Bacteria, yeast and other fungi - longterm antibiotic, antimycotic free culture: Not detected
NUMBER OF REPLICATE TISSUES: 3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- Fresh tissues
- N. of replicates : 3
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be non-irritant to skin if the viability after exposure is greater than or equal to 50% . - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg to cover the skin uniformly with an area of 0.63 cm². The test item is a fine powder. For better contact of the test item to the skin, the skin surface was moistened with 25 µL Dulbecco’s phosphate buffered saline.
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): Dulbecco's phosphate buffered saline (D-PBS) 30µL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): aqueous sodium dodecyl sulphate (SDS) 30 µL
- Concentration (if solution): 5% - Duration of treatment / exposure:
- 60 min
- Duration of post-treatment incubation (if applicable):
- 42h
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- test substance
- Value:
- 117.2
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- optical density was 1.418
- Positive controls validity:
- valid
- Remarks:
- viability 6.1% of the negative control
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: Not reported
- Direct-MTT reduction: no
- Colour interference with MTT: no
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The absolute OD of the negative control (NC) tissues (treated with sterile PBS buffer) in the MTT test is an indicator of tissue viability obtained in the testing laboratory after shipping and storing procedures and under specific conditions of use. The assay meets the acceptance criterion if the mean OD of the NC tissues is ≥ 1.0 and ≤ 2.5. The mean optical density (OD) of 3 negative control tissues was 1.418.
- Acceptance criteria met for positive control: The assay meets the acceptance criterion if the mean viability of PC tissues expressed as % of the negative control tissues is ≤ 20%. The viability of cells treated with the positive reference item, 5% SDS, was 6.1% of the negative control and fulfilled the acceptance criterion of ≤ 20%.
- Acceptance criteria met for variability between replicate measurements: The assay meets the acceptance criterion if the standard deviation (SD) calculated from individual % tissue viabilities of the 3 identically treated replicates is ≤ 18%. The standard deviation determined for all triplicates was below the limit of acceptance of 18%. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In a study with alpha methyl glucoside conducted according to OECD guideline 439, the skin irritation was determined in vitro using the reconstructed human epidermis model EPIDERM ™. The cell viability was determined using the MTT assay. Since the cell viability was 117.2 % in this test and all validity criteria were fulfiled alpha methyl glucoside is considered to be non-irritating to the skin.
- Executive summary:
In a study with alpha methyl glucoside conducted according to OECD guideline 439, the skin irritation was determined in vitro using the reconstructed human epidermis model EPIDERM ™. The three-dimensional human epidermis model tissue was exposed to 25 mg of the test substance on a surface area of 0.63cm² in triplicates for 60 min and subsequently washed and incubated for further 42h. Cytotoxicity (irritancy) was expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT at the end of the treatment.
The positive (5% SDS) and negative (deionised water) control gave responses that were within the acceptance criteria and as such demonstrated the validity of the study.
The relative mean tissue viability obtained after 60 minutes treatment with alpha methyl glucoside compared to the negative control tissues was 117.2 %. Since the mean relative tissue viability for the test substance was above 50%, alpha methyl glucoside is identified to be not irritating.
Reference
The optical pre-experiment (colour interference pre-experiment) to investigate the test item’s colour change potential in water did not led to a change in colour. Optical evaluation of the MTT-reducing capacity of the test item after 1 hour incubation with MTT-reagent did not show blue colour.
Table 1: Summary of results
Group |
Absorbance 570 nm Tissue 1 |
Absorbance 570 nm Tissue 2 |
Absorbance 570 nm Tissue 3 |
Mean Absorbance of 3 Tissues |
Relative Standard Deviation [%] |
Rel. Absorbance [% of Negative Control] |
Negative control |
1.503 |
1.319 |
1.431 |
1.418 |
6.6 |
100.0 |
Positive control |
0.092 |
0.083 |
0.085 |
0.087 |
5.3 |
6.1 |
Test item |
1.557 |
1.624 |
1.807 |
1.663 |
7.8 |
117.2 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-03-06 to 2017-05-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Version / remarks:
- July 26, 2013
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Version / remarks:
- December 09, 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Hubert Bahlmann GmbH & Co. Versandschlachterei Spezialmischfutterwerk KG, 49699 Lindern, Germany
- Number of animals: at least five, three corneae for each concentration (negative control, positive control, treatment)
- Characteristics of donor animals (e.g. age, sex, weight): between 6 and 12 month old cattle
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): To minimize deterioration and bacterial contamination, on collection the eyes were completely submerged in Hanks’ Balanced Salt Solution 2 (HBSS) containing penicillin at 100 IU/mL and streptomycin at 100 µg/mL.
- indication of any existing defects or lesions in ocular tissue samples: Upon arrival at the laboratory, the eyes were examined for defects such as but not limited to increased opacity, scratches, and neovascularisation. Only corneas from eyes free of defects were used.
- Indication of any antibiotics used: penicillin at 100 IU/mL and streptomycin at 100 µg/mL - Vehicle:
- unchanged (no vehicle)
- Remarks:
- 20% suspension in 0.9% sodium chloride solution (w/v)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 750 µL
- Concentration (if solution): 20% suspension in 0.9% sodium chloride solution (w/v)
- Duration of treatment / exposure:
- 240 min
- Duration of post- treatment incubation (in vitro):
- 90 ± 5 min
- Number of animals or in vitro replicates:
- three corneae per treatment
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAE
Bovine eyes from cattle in the age range of 6 to 12 months were obtained from a slaughterhouse. To minimize deterioration and bacterial contamination, on collection the eyes were completely submerged in Hanks’ Balanced Salt Solution 2 (HBSS) containing penicillin at 100 IU/mL and streptomycin at 100 µg/mL 3 . Upon arrival at the laboratory, the eyes were examined for defects such as but not limited to increased opacity, scratches, and neovascularisation. Only corneas from eyes free of defects were used.
NUMBER OF REPLICATES
Three coneae per concentration
SOLVENT CONTROL USED (if applicable)
0.9 % sodium chloride solution (w/v)
POSITIVE CONTROL USED
20% Imidazole in 0.9% sodium chloride solution
APPLICATION DOSE AND EXPOSURE TIME
750 µL of each solution was applied for 240 min
TREATMENT METHOD: open chamber
POST-INCUBATION PERIOD: no
REMOVAL OF TEST SUBSTANCE
- Number of washing steps after exposure period: at least three times
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was determined by the amount of light transmission through the cornea measured quantitatively with the aid of an opacitometer
- Corneal permeability: passage of sodium fluorescein dye measured with the aid of microtiter plate reader (OD490)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA: The IVIS cut-off values for identifying test chemicals as inducing serious damage (UN GHS Category 1) and test chemicals not requiring classification for irritation or serious eye damage (UN GHS No Category):
≤ 3: No Category
> 3 and ≤ 55: No prediction can be made
> 55: Category 1 - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 1
- Value:
- 2.097
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 1
- Value:
- -1.99
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- fluorescein retention score
- Run / experiment:
- 1
- Value:
- -0.007
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: No
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes. The negative or solvent/vehicle control responses should result in opacity and permeability values, that are less than the established upper limits for background opacity and permeability values for bovine corneas treated with the respective negative or solvent/vehicle control. (see Table 1)
- Acceptance criteria met for positive control: Yes. The positive control should give an IVIS that falls within two standard deviations of the current historical mean. (see Table 1)
- Range of historical values if different from the ones specified in the test guideline: No - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In the present study with alpha methyl glucoside conducted according to OECD guideline 437, three corneae for each treatment, i.e. negative control, positive control (20% imidazol in 0.9 % sodium chloride solution (w/v)) and treatement (20% alpha methyl glucoside in 0.9 % sodium chloride solution (w/v)) were exposed for 240 min. Opacity and permeability revealed values < 0 and the IVIS was < 3 (2.097), therefore, the test item is not classified according to UN GHS classification.
- Executive summary:
In the present study with alpha methyl glucoside conducted according to OECD guideline 437, three corneae for each concentration, i.e. negative control, positive control (20% imidazol in 0.9 % sodium chloride solution (w/v)) and treatement (20% alpha methyl glucoside in 0.9 % sodium chloride solution (w/v)) were exposed for 240 min. Subsequently the opacity was determined using a opacitometer and the corneal permeability was detected with the fluorescein method.
The positive control increased opacity and permeability (mean in vitro score 79.07) corresponding to a classification as irreversible effects to the eye.
With the negative control (saline) neither an increase of opacity nor permeability of the corneae could be observed (mean in vitro score 0.00).
Since, the results of the test item for opacity and permeability revealed values < 0 and the IVIS was < 3 (2.097) the test item is not classified according to Regulation (EC) No 1272/2008 (CLP) and the Globally Harmonized System for Classification and Labelling of Chemicals (GHS).
Reference
Table 1: Historical control data
|
Parameter |
Mean |
Standard deviation |
Lower limit of acceptance (mean-2*SD) |
Upper limit of acceptance (mean+2*SD) |
NaCl 0.9 % |
IVIS Opacity |
0.812 0.513 |
0.762 0.788 |
-0.712 -1.064 |
2.336 2.089 |
|
Permeability |
0.020 |
0.012 |
-0.005 |
0.045 |
Imidazol 20% |
IVIS Opacity |
86.039 63.051 |
10.607 10.709 |
64.826 41.634 |
107.253 84.468 |
|
Permeability |
1.533 |
0.463 |
0.607 |
2.458 |
Table 2: Summary of results after 240 min incubation
Test group |
Opacity |
Permeability at 490 nm |
In vitro Irritation score |
Mean In vitro Irritation Score |
In vitro Irritation Scale |
Negative control |
0.917 |
0.010 |
1.067 |
|
Not severely irritating |
-0.797 |
0.011 |
-0.632 |
|
||
-0.358 |
0.010 |
-0.208 |
0.076 |
||
Positive control |
73.505 |
1.403 |
94.629 |
|
Severely irritating |
49.323 |
1.204 |
67.462 |
|
||
54.463 |
1.372 |
75.122 |
79.071 |
||
Test item |
-2.032 |
0.006 |
-2.043 |
|
Not severely irritating |
-2.031 |
0.005 |
-2.027 |
|
||
-2.151 |
-0.010 |
-2.222 |
-2.097 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
- skin irritation:
In a study conducted according to OECD guideline 439, the skin irritation was determined in vitro using the reconstructed human epidermis model EPIDERM ™. The three-dimensional human epidermis model tissuewas exposed to 25 mg of the test substance on a surface area of 0.63cm² in triplicates for 60 min and subsequently washed and incubated for further 42h.Cytotoxicity (irritancy) was expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT at the end of the treatment.
The positive (5% SDS) and negative (deionised water) control gave responses that were within the acceptance criteria and as such demonstrated the validity of the study.
The relative mean tissue viability obtained after 60 minutes treatment with alpha methyl glucoside compared to the negative control tissues was 117.2 %. Since the mean relative tissue viability for the test substance was above 50%, alpha methyl glucoside is identified to be not irritating.
- eye irritation:
In the present study conducted according to OECD guideline 437, three corneae for each treatment, i.e. negative control, positive control (20% imidazol in 0.9 % sodium chloride solution (w/v)) and treatement (20% alpha methyl glucoside in 0.9 % sodium chloride solution (w/v)) were exposed for 240 min. Subsequently, the opacity was determined using a opacitometer and the corneal permeability was detected with the fluorescein method.
The positive control increased opacity and permeability (mean in vitro score 79.07) corresponding to a classification as corrosive to the eye.
With the negative control (saline) neither an increase of opacity nor permeability of the corneae could be observed (mean in vitro score 0.00).
Since, the results of the test item for opacity and permeability revealed values < 0 and the IVIS was < 3 the test item is considered to be not severe irritant or not corrosive.
Justification for classification or non-classification
Based on reliable, adequate and relevant data the substance does not need to be classified according to Regulation (EC) No 1272/2008 (CLP) and the Globally Harmonized System for Classification and Labelling of Chemicals (GHS) with repsect to skin/eye irritation or corrosion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.